- Home
- TOP vs IPSC Comparison
TOP vs IPSC Comparison
Compare TOP & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOP
- IPSC
- Stock Information
- Founded
- TOP 2015
- IPSC 2019
- Country
- TOP Singapore
- IPSC United States
- Employees
- TOP N/A
- IPSC N/A
- Industry
- TOP Investment Bankers/Brokers/Service
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- TOP Finance
- IPSC Health Care
- Exchange
- TOP Nasdaq
- IPSC Nasdaq
- Market Cap
- TOP 43.0M
- IPSC 49.1M
- IPO Year
- TOP 2022
- IPSC 2021
- Fundamental
- Price
- TOP $1.03
- IPSC $0.49
- Analyst Decision
- TOP
- IPSC Strong Buy
- Analyst Count
- TOP 0
- IPSC 6
- Target Price
- TOP N/A
- IPSC $3.00
- AVG Volume (30 Days)
- TOP 60.9K
- IPSC 1.5M
- Earning Date
- TOP 08-13-2025
- IPSC 11-13-2025
- Dividend Yield
- TOP N/A
- IPSC N/A
- EPS Growth
- TOP N/A
- IPSC N/A
- EPS
- TOP N/A
- IPSC N/A
- Revenue
- TOP $3,329,256.00
- IPSC $113,337,000.00
- Revenue This Year
- TOP N/A
- IPSC $1,589.94
- Revenue Next Year
- TOP N/A
- IPSC N/A
- P/E Ratio
- TOP N/A
- IPSC N/A
- Revenue Growth
- TOP N/A
- IPSC 4122.69
- 52 Week Low
- TOP $1.00
- IPSC $0.34
- 52 Week High
- TOP $3.33
- IPSC $1.83
- Technical
- Relative Strength Index (RSI)
- TOP 34.31
- IPSC 41.07
- Support Level
- TOP $1.03
- IPSC $0.44
- Resistance Level
- TOP $1.07
- IPSC $0.52
- Average True Range (ATR)
- TOP 0.05
- IPSC 0.05
- MACD
- TOP -0.00
- IPSC -0.01
- Stochastic Oscillator
- TOP 20.37
- IPSC 24.51
About TOP TOP Financial Group Limited
TOP Financial Group Ltd is an online brokerage firm in Hong Kong specializing in trading local and overseas equities, futures, and options products. The Company generates brokerage commission income by enabling its customers to trade on multiple exchanges present globally. The company operates in only one segment which is the futures brokerage service.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.